Topical microbicides: the time has come.AIDS Read. 2006 Mar; 16(3):144-8, 155-8, 161; discussion 148, 156-7.AR
Abstract
Microbicides are vaginally or rectally applied drugs that inhibit HIV and other sexually transmitted pathogens. About 30 microbicidal products are being studied in preclinical and clinical trials. Data from in vitro, animal, and in vivo investigations with candidate microbicidal compounds support a proof of concept, although large-scale clinical trials will determine efficacy. Because there are multiple targets for HIV infection in the genital tract, synergistic combinations of microbicides will probably offer the greatest protection for non-HIV-infected persons and might decrease transmissibility when used by those infected with HIV.
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
16538955
Citation
Dhawan, Darpun, et al. "Topical Microbicides: the Time Has Come." The AIDS Reader, vol. 16, no. 3, 2006, pp. 144-8, 155-8, 161; discussion 148, 156-7.
Dhawan D, Keller M, Klotman ME. Topical microbicides: the time has come. AIDS Read. 2006;16(3):144-8, 155-8, 161; discussion 148, 156-7.
Dhawan, D., Keller, M., & Klotman, M. E. (2006). Topical microbicides: the time has come. The AIDS Reader, 16(3), 144-8, 155-8, 161; discussion 148, 156-7.
Dhawan D, Keller M, Klotman ME. Topical Microbicides: the Time Has Come. AIDS Read. 2006;16(3):144-8, 155-8, 161; discussion 148, 156-7. PubMed PMID: 16538955.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Topical microbicides: the time has come.
AU - Dhawan,Darpun,
AU - Keller,Marla,
AU - Klotman,Mary E,
PY - 2006/3/17/pubmed
PY - 2006/4/28/medline
PY - 2006/3/17/entrez
SP - 144-8, 155-8, 161; discussion 148, 156-7
JF - The AIDS reader
JO - AIDS Read
VL - 16
IS - 3
N2 - Microbicides are vaginally or rectally applied drugs that inhibit HIV and other sexually transmitted pathogens. About 30 microbicidal products are being studied in preclinical and clinical trials. Data from in vitro, animal, and in vivo investigations with candidate microbicidal compounds support a proof of concept, although large-scale clinical trials will determine efficacy. Because there are multiple targets for HIV infection in the genital tract, synergistic combinations of microbicides will probably offer the greatest protection for non-HIV-infected persons and might decrease transmissibility when used by those infected with HIV.
SN - 1053-0894
UR - https://www.unboundmedicine.com/medline/citation/16538955/Topical_microbicides:_the_time_has_come_
DB - PRIME
DP - Unbound Medicine
ER -